Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee 77030, USA.
J Am Med Inform Assoc. 2012 May-Jun;19(3):346-52. doi: 10.1136/amiajnl-2011-000185. Epub 2011 Aug 17.
Alerting systems, a type of clinical decision support, are increasingly prevalent in healthcare, yet few studies have concurrently measured the appropriateness of alerts with provider responses to alerts. Recent reports of suboptimal alert system design and implementation highlight the need for better evaluation to inform future designs. The authors present a comprehensive framework for evaluating the clinical appropriateness of synchronous, interruptive medication safety alerts.
Through literature review and iterative testing, metrics were developed that describe successes, justifiable overrides, provider non-adherence, and unintended adverse consequences of clinical decision support alerts. The framework was validated by applying it to a medication alerting system for patients with acute kidney injury (AKI).
Through expert review, the framework assesses each alert episode for appropriateness of the alert display and the necessity and urgency of a clinical response. Primary outcomes of the framework include the false positive alert rate, alert override rate, provider non-adherence rate, and rate of provider response appropriateness. Application of the framework to evaluate an existing AKI medication alerting system provided a more complete understanding of the process outcomes measured in the AKI medication alerting system. The authors confirmed that previous alerts and provider responses were most often appropriate.
The new evaluation model offers a potentially effective method for assessing the clinical appropriateness of synchronous interruptive medication alerts prior to evaluating patient outcomes in a comparative trial. More work can determine the generalizability of the framework for use in other settings and other alert types.
警示系统是一种临床决策支持工具,在医疗保健领域越来越普遍,但很少有研究同时衡量警示的适当性和医务人员对警示的反应。最近有报道称,警示系统的设计和实施存在不足之处,这凸显了需要更好的评估方法来为未来的设计提供信息。作者提出了一个全面的框架,用于评估同步、中断式药物安全警示的临床适宜性。
通过文献回顾和迭代测试,制定了描述成功、合理的忽略、医务人员不遵守以及临床决策支持警示的意外不良后果的指标。该框架通过应用于急性肾损伤(AKI)患者的药物警示系统进行了验证。
通过专家审查,该框架评估每个警示事件的警示显示的适宜性以及临床反应的必要性和紧迫性。该框架的主要结果包括假阳性警示率、警示忽略率、医务人员不遵守率和医务人员反应适宜率。该框架应用于评估现有的 AKI 药物警示系统,更全面地了解 AKI 药物警示系统中测量的过程结果。作者证实,以前的警示和医务人员的反应通常是适当的。
新的评估模型为在比较试验中评估患者结果之前,评估同步中断式药物警示的临床适宜性提供了一种潜在有效的方法。进一步的工作可以确定该框架在其他环境和其他警示类型中的通用性。